Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome

Infection and Immunity

Volumn 70, Issue 9, 2002, Pages 5008-5018

  Bowes, Tyrone ^a   Wagner, Eric R ^a   Boffey, Judith ^a   Nicholl, Dawn ^a   Cochrane, Lynne ^a   Benboubetra, Mustapha ^a   Conner, Joe ^a   Furukawa, Keiko ^a   Furukawa, Koichi ^a   Willison, Hugh J ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD40 ANTIGEN; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD3; GANGLIOSIDE GM3; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; LIPID A; N ACETYLGALACTOSAMINYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; GUILLAIN BARRE SYNDROME; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, CD40; AUTOANTIBODIES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SEQUENCE; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNIZATION; LIPOPOLYSACCHARIDES; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, KNOCKOUT; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; N-ACETYLGALACTOSAMINYLTRANSFERASES; SELF TOLERANCE;

EID: 0036716368     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.9.5008-5018.2002     Document Type: Article

References (66)

1. Generation of human monoclonal antibodies against ganglioside antigens and their applications in the diagnosis and therapy of cancer
2. Association between Campylobacter infection and Guillain-Barre syndrome
3. Toll signaling pathways in the innate immune response
4. Guillain-Barre syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits
5. Differential immune response to gangliosides in Guillain-Barre syndrome patients from Japan and The Netherlands
6. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barre and Miller Fisher patients
7. Rapidly progressive, predominantly motor Guillain-Barre syndrome with anti-GalNAc-GD1a antibodies
8. Pathogenetic role of autoantibodies in neurological diseases
9. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre syndrome patients mimic human gangliosides in structure
10. Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide
11. Lipopolysaccharides of Campylobacter jejuni serotype O:19: Structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barre syndrome
12. Enhanced in vivo immune responses to bacterial lipopolysaccharide by exogenous CD40 stimulation
13. Tlr4: Central component of the sole mammalian LPS sensor
14. Genes coding evolutionary novel anti-carbohydrate antibodies: Studies on anti-Gal production in alpha 1,3 galactosyltransferase knock out mice
15. Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity
16. Enhancement of T cell-independent immune responses in vivo by CD40 antibodies
17. T-independent immune response: New aspects of B cell biology
18. Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations
19. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro
20. CD1-specific T cells in microbial immunity
21. Guillain-Barre syndrome
22. Autoimmunity in the peripheral nervous system
23. Immunopathogenesis and treatment of the Guillain-Barre syndrome-part II
24. Transgenic B lymphocytes expressing a human cold agglutinin escape tolerance following experimental infection of mice by Mycoplasma pulmonis
25. Monoclonal antibodies to murine CD40 define two distinct functional epitopes
26. GD3 vaccines for melanoma: Superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines
27. Human autoimmune neuropathies
28. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome
29. Pathogenesis of Guillain-Barre syndrome
30. Clinical and epidemiologic features of Guillain-Barre syndrome
31. Specific immunization using keyhole limpet hemocyanin-ganglioside conjugates
32. Antibody responses to ganglio-series gangliosides in different strains of inbred mice
33. The role of Toll-like receptors in host defense against microbial infection
34. Gangliosides of the neuron
35. Gangliosides: Structure, isolation, and analysis
36. Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni
37. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis
38. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization
39. B1 cells: Similarities and differences with other B cell subsets
40. Techniques for encapsulating bioactive agents into liposomes
41. T cell-independent antigens type 2
42. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides
43. Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: Implications in pathogenesis
44. Serotyping of Campylobacter jejuni based on heat-stable antigens: Relevance, molecular basis and implications in pathogenesis
45. Potential role of lipopolysaccharide of Campylobacter jejuni in the development of Guillain-Barre syndrome
46. Campylobacter species and Guillain-Barre syndrome
47. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain
48. Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides
49. Diversity of lipopolysaccharide structures in Campylobacter jejuni
50. Lipopolysaccharides in the development of Guillain-Barre syndrome and Miller Fisher forms of acute inflammatory peripheral neuropathies
51. Host resistance to infection: Genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes
52. The Lps locus: Genetic regulation of host responses to bacterial lipopolysaccharide
53. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3
54. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection
55. Molecular mimicry in Guillain-Barre syndrome
56. An in vitro model for T cell-independent induction of humoral immunity. A requirement for NK cells
57. Pathways for lipid antigen presentation by CD1 molecules: Nowhere for intracellular pathogens to hide
58. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system
59. Gangliosides and modulation of the function of neural cells
60. Biochemistry and genetics of the ABO, Lewis, and P blood group systems
61. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome
62. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies
63. Guillain Barre syndrome
64. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barre syndrome and Fisher's syndrome
65. Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside